Autolus Therapeutics plc (AUTL)
AUTL Price and Sentiment
AUTL Latest news
Tetracycline and minocycline controllable CAR T cell system to manage toxicities Tetracycline and minocycline controllable CAR T cell system to manage toxicities
Market Highlights: Stocks react to earnings release, Blackstone invests $250 billion in Autolus, Elon Musk to sell 10% Tesla stake2021-11-09 08:30
Roblox Corp (NYSE: RBLX) shares jumped 30% after hours on Monday after the company posted robust fiscal Q3 results thanks to demand surge with the easing of COVID-19 restrictions. As a result, the video game company reported a loss of $74 million or $0.13 per share compared to a net loss of $48.6 million or […] The post Market Highlights: Stocks react to earnings release, Blackstone invests $250 billion in Autolus, Elon Musk to sell 10% Tesla stake appeared first on Invezz.
A private equity firm is taking a $100 million stake in the biotech.
Chinese education stocks are moving higher on Monday as reports claim China will allow companies to resume their after-school tutoring. The post Chinese Stocks Alert: The Turnaround Story Driving TAL, EDU, METX, GOTU Stocks Higher appeared first on InvestorPlace.
Autolus Therapeutics (AUTL) stock is surging higher in trading Monday following news of a major investment in the company. The post AUTL Stock: Why Little-Known Autolus Therapeutics Is Rocketing Higher Today appeared first on InvestorPlace.
Shares of Autolus Therapeutics plc (NASDAQ: AUTL) jumped about 30% in premarket trading on Monday after it said Blackstone Life Sciences agreed to invest up to $250 million to fund the development of its new therapy for Leukemia. Blackstone is taking a sizable equity stake in Autolus Blackstone is taking an equity stake worth $100 […] The post Blackstone triggers a 30% increase in Autolus Therapeutics shares appeared first on Invezz.
The stock price of Autolus Therapeutics PLC (NASDAQ: AUTL) increased by over 25% pre-market today. This is why it happened.
Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platform2021-11-08 02:00
– One of the largest private financings of a UK biotech company, and the largest from a single source – continues Blackstone conviction in the country
- Demonstrates progress on the Company's commercial manufacturing process and builds on positive obe-cel clinical data presented at EHA
Autolus Therapeutics plc (AUTL) CEO Dr. Christian Itin on Q3 2021 Results - Earnings Call Transcript2021-11-03 22:00
Autolus Therapeutics plc (AUTL) CEO Dr. Christian Itin on Q3 2021 Results - Earnings Call Transcript